Clinical outcomes and prognostic factors of patients with advanced hepatocellular carcinoma treated with sorafenib as first-line therapy: A Korean multicenter study
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical outcomes and prognostic factors of patients with advanced hepatocellular carcinoma treated with sorafenib as first-line therapy: A Korean multicenter study
Authors
Keywords
-
Journal
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Volume 29, Issue 7, Pages 1463-1469
Publisher
Wiley
Online
2014-02-12
DOI
10.1111/jgh.12542
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Early increase in α-fetoprotein for predicting unfavorable clinical outcomes in patients with advanced hepatocellular carcinoma treated with sorafenib
- (2013) Takahide Nakazawa et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- The predictive role of skin rash with cetuximab and panitumumab in colorectal cancer patients: a systematic review and meta-analysis of published trials
- (2013) F. Petrelli et al. Targeted Oncology
- Genetic predisposition of hand-foot skin reaction after sorafenib therapy in patients with hepatocellular carcinoma
- (2012) Joo Ho Lee et al. CANCER
- The use of single-agent sorafenib in the treatment of advanced hepatocellular carcinoma patients with underlying Child-Pugh B liver cirrhosis
- (2012) Joanne Chiu et al. CANCER
- How to Improve Treatment Outcomes for Hepatocellular Carcinoma of Intermediate and Advanced Stage
- (2012) Do Young Kim et al. DIGESTIVE DISEASES
- First interim analysis of the GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib) non-interventional study
- (2012) R. Lencioni et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Alpha-fetoprotein response correlates with EASL response and survival in solitary hepatocellular carcinoma treated with transarterial therapies: A subgroup analysis
- (2012) Khairuddin Memon et al. JOURNAL OF HEPATOLOGY
- Sorafenib Dose Escalation in the Treatment of Advanced Hepatocellular Carcinoma
- (2012) Jeong Eun Kim et al. ONCOLOGY
- Evaluation of the mRECIST and a-Fetoprotein Ratio for Stratification of the Prognosis of Advanced-Hepatocellular-Carcinoma Patients Treated with Sorafenib
- (2012) Tomokazu Kawaoka et al. ONCOLOGY
- Diarrhea Is a Positive Outcome Predictor for Sorafenib Treatment of Advanced Hepatocellular Carcinoma
- (2012) Ronald Koschny et al. ONCOLOGY
- Efficacy, Safety, and Survival Factors for Sorafenib Treatment in Japanese Patients with Advanced Hepatocellular Carcinoma
- (2012) Masahito Nakano et al. ONCOLOGY
- A single center experience of sorafenib in advanced hepatocellular carcinoma patients
- (2011) Tianqiang Song et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Integrative Genomic Identification of Genes on 8p Associated With Hepatocellular Carcinoma Progression and Patient Survival
- (2011) Stephanie Roessler et al. GASTROENTEROLOGY
- Management of hepatocellular carcinoma: An update
- (2011) Jordi Bruix et al. HEPATOLOGY
- Prognostic Factors in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib: A Retrospective Comparison with Previously Known Prognostic Models
- (2011) Kyung Kee Baek et al. ONCOLOGY
- Early Skin Toxicity as a Predictive Factor for Tumor Control in Hepatocellular Carcinoma Patients Treated with Sorafenib
- (2010) B. Vincenzi et al. ONCOLOGIST
- Safety and Efficacy of Sorafenib in Patients With Advanced Hepatocellular Carcinoma in Consideration of Concomitant Stage of Liver Cirrhosis
- (2009) Marcus Alexander Wörns et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Pilot clinical trial of localized concurrent chemoradiation therapy for locally advanced hepatocellular carcinoma with portal vein thrombosis
- (2008) Kwang-Hyub Han et al. CANCER
- Hepatocellular carcinoma presenting with bone metastasis: clinical characteristics and prognostic factors
- (2008) Seung Up Kim et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma
- (2008) Yujin Hoshida et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started